BLS sees potential FY27 ‘upside’ as UK facility nears launch by Adam Sheldon September 8, 2026September 9, 2026 BLS Pharmaceuticals has flagged a potential increase to its FY27 revenue guidance, revealing its forecast of […]
‘This is just the beginning’: BLS CEO on German expansion and vision for firm by Adam Sheldon August 6, 2026August 6, 2026
